(IMNP) |
0 (0%) 04-24 18:32 |
Open: | |
High: | |
Low: | |
Volume: | 0 |
Market Cap: | 0(M) |
PE Ratio: | 0 |
Exchange: | |
Industry: | |
Sector: |
Technical analysis | ||||
sell | buy |
Resistance 2: | 10.64 |
Resistance 1: | 10.61 |
Pivot price: | 0.00 |
Support 1: | 10.57 |
Support 2: | 8.79 |
52w High: | |
52w Low: |
EPS | 0.000 |
Book Value | 0.000 |
PEG Ratio | 0.00 |
Gross Profit | 0.000 |
Profit Margin (%) | 0.00 |
Operating Margin (%) | 0.00 |
Return on Assets (ttm) | 0.0 |
Return on Equity (ttm) | 0.0 |
Sun, 01 May 2022
Immune modulating nanoparticles depleting tumor-associated macrophages to enhance immune checkpoint blockade ... - ScienceDirect.com
Tue, 30 Mar 2021
IMNP: Large Market Opportunity for Bertilimumab in the Treatment of Inflammatory Bowel Diseases - Zacks Small Cap Research
Wed, 27 Sep 2017
Immune Pharmaceuticals Announces Positive Results from Ongoing Phase 2 Trial of Bertilimumab in Bullous ... - Business Wire
Wed, 24 Apr 2024
Wed, 24 Apr 2024
Wed, 24 Apr 2024
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |